ADANIR, H. Et Al. 2021. Efficacy and Safety of Tenofovir Alafenamide in Hepatitis B Virus-Infected Patients with Chronic Hemodialysis and Renal Transplantation: A Preliminary Result (785). AASLD the Liver Meeting Digital Experience , (United States Of America), 480-481.

ADANIR, H., ÖZER ETİK, D., YILDIRIM, A. E., MEHDİYEV, S., YAPALI, S., COŞAR, A. M., ... ARI, D.(2021). Efficacy and Safety of Tenofovir Alafenamide in Hepatitis B Virus-Infected Patients with Chronic Hemodialysis and Renal Transplantation: A Preliminary Result (785) . AASLD the Liver Meeting Digital Experience (pp.480-481). , United States Of America

ADANIR, HAYDAR Et Al. "Efficacy and Safety of Tenofovir Alafenamide in Hepatitis B Virus-Infected Patients with Chronic Hemodialysis and Renal Transplantation: A Preliminary Result (785)," AASLD the Liver Meeting Digital Experience, United States Of America, 2021

ADANIR, HAYDAR Et Al. "Efficacy and Safety of Tenofovir Alafenamide in Hepatitis B Virus-Infected Patients with Chronic Hemodialysis and Renal Transplantation: A Preliminary Result (785)." AASLD the Liver Meeting Digital Experience , United States Of America, pp.480-481, 2021

ADANIR, H. Et Al. (2021) . "Efficacy and Safety of Tenofovir Alafenamide in Hepatitis B Virus-Infected Patients with Chronic Hemodialysis and Renal Transplantation: A Preliminary Result (785)." AASLD the Liver Meeting Digital Experience , United States Of America, pp.480-481.

@conferencepaper{conferencepaper, author={HAYDAR ADANIR Et Al. }, title={Efficacy and Safety of Tenofovir Alafenamide in Hepatitis B Virus-Infected Patients with Chronic Hemodialysis and Renal Transplantation: A Preliminary Result (785)}, congress name={AASLD the Liver Meeting Digital Experience}, city={}, country={United States Of America}, year={2021}, pages={480-481} }